ZEMOCIMIG
UNII SZN3M97G43

Substance Identification & Data

This profile provides standardized clinical and technical data for Zemocimig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) SZN3M97G43.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2955620-21-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

SZN3M97G43

CAS Registry Number

2955620-21-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZEMOCIMIG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C215269

National Cancer Institute reference terminology for clinical and research data.

INN ID

13346

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zemocimig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZEMOCIMIG

Common Names & Synonyms

IMMUNOGLOBULIN (H-GAMMA4_L-KAPPA)_( H-GAMMA4_L-LAMBDA2), ANTI-(HOMO SAPIENS F9A (COAGULATION FACTOR F9, COAGULATION FACTOR IX, HEMOPHILIA B) ACTIVATED ) AND ANTI-(HOMO SAPIENS F10 (COAGULATION FACTOR 10, COAGULATION FACTOR X)), HUMANIZED AND HOMO SAPIENS MONOCLONAL ANTIBODY, BISPECIFIC, BIVALENT

IMMUNOGLOBULIN G4 (180-LYSINE,201-GLUTAMINE,230-PROLINE,298-TYROSINE,358-LYSINE,411-LYSINE,430-LEUCINE,436-ALANINE,440-ARGININE,442-GLUTAMIC ACID,447-PROLINE,DE-448-GLYCINE,DE-449-LYSINE), BISPECIFIC, ANTI-(HUMAN/MACACA FASCICULARIS BLOOD-COAGULATION FACTOR IXA) (HUMAN-RATTUS NORVEGICUS MONOCLONAL AAE0252 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AAE0252 .KAPPA.-CHAIN, (228->225'),(231->228')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G4 (149-GLUTAMIC ACID,177-GLUTAMIC ACID,198-GLUTAMINE,227-PROLINE,295-TYROSINE,408-LYSINE,427-LEUCINE,433-ALANINE,437-ARGININE,438-GLUTAMIC ACID,439-GLUTAMIC ACID,444-PROLINE,DE-445-GLYCINE,DE-446-LYSINE) ANTI-(HUMAN BLOOD-COAGULATION FACTOR X) (HUMAN-MUS MUSCULUS MONOCLONAL AAE0252 .GAMMA.4-CHAIN) DISULFIDE WITH HUMAN MONOCLONAL AAE0252 .LAMBDA.-CHAIN

ZEMOCIMIG [INN]

External Clinical & Regulatory Resources

Previous UNIISZN3F6U556

Next UNIISZO88P62VN